A Lancaster County hemp entrepreneur is watching Washington closely as Congress weighs a December deadline that could reshape, or eliminate, the consumable hemp market in Pennsylvania. Jake Sitler, founder of the hemp wellness brand Endo and president of the Pennsylvania Hemp and Cannabis Guild, is opening retail locations in Lancaster and Marietta even as federal lawmakers debate closing what they call a regulatory loophole tied to the 2018 Farm Bill. The stakes are not abstract for operators like him: a full ban or a poorly drafted restriction could unwind a supply chain that Pennsylvania's hemp industry has built over roughly seven years.
The core tension is structural. The 2018 Farm Bill legalized hemp and its derivatives at concentrations below 0.3% Delta-9 THC by dry weight, which opened the door to CBD beverages, gummies, and topicals sold outside the tightly licensed medical and adult-use cannabis channels that most states, including Pennsylvania, still operate under separately. That distinction matters for anyone tracking compliance: dispensaries selling regulated cannabis products answer to state seed-to-sale tracking, lab testing requirements, and excise tax schedules, while hemp-derived goods have largely existed in a lighter-touch federal framework. Retailers navigating both markets, or considering entry into adjacent states, increasingly rely on integrated retail tools; some operators evaluating multi-state footprints, for instance, look toward platforms like software for cannabis dispensary vermont to manage compliance documentation and point-of-sale requirements as rules diverge state by state. software for cannabis dispensary vermont
Why Lawmakers Are Pushing Back
Pennsylvania Attorney General Dave Sunday has flagged the lack of guardrails around hemp-derived intoxicants as his central concern, not the existence of the products themselves. That framing lines up with a broader pattern showing up in statehouses nationally: officials are less focused on banning CBD outright and more focused on the absence of age verification, potency labeling, and consistent lab testing for products that can contain Delta-9 THC in amounts sufficient to intoxicate. Without a COA, a certificate of analysis, attached to every batch, buyers and regulators alike have limited ability to confirm what is actually in a bottle or gummy jar sitting on a convenience-store shelf.
That gap is exactly what critics call the wild west problem. Unlike state-licensed dispensaries, which operate under METRC or comparable track-and-trace systems, mandatory child-resistant and compliant packaging, and routine inventory audits, many hemp retailers have operated with far less oversight. Sitler says he posts 21-and-over signage voluntarily and supports regulation, a stance that separates responsible operators from the segment of the market that has drawn regulatory scrutiny.
What a Ban or New Rules Would Mean for Business
For farmers and small retailers, the immediate risk is financial whiplash. Pennsylvania's hemp sector, estimated to generate roughly a billion dollars annually, involves growers, processors, wholesalers, and storefronts that have built inventory, signed leases, and hired staff around the current federal framework. A sudden ban would strand that investment; a workable compromise, by contrast, would likely mean new compliance costs, lab testing mandates, and packaging standards that mirror what licensed cannabis dispensaries already absorb.
Sitler's advocacy through the Pennsylvania Hemp and Cannabis Guild centers on protecting agricultural production while accepting tighter consumer-safety rules, a middle path he argues preserves farmer income without leaving children exposed to unregulated intoxicating products. Whether Congress lands there, or opts for a blanket restriction, will determine whether Pennsylvania's hemp retailers spend 2025 investing in compliance infrastructure or winding down operations entirely.